Go to CARM Main Page

The Council for Advanced Regenerative Medicine (CARM) is an association of companies established for the purposes of fostering the RM industry in Korea and pioneering the global RM market.
CARM is also aiming at expanding collaborations on RM with domestic and international partners including government organizations, other associations/societies, academic institutions, patient groups and the public.

• 2023 March Participate in the 1st Forum of Korea Federation of Pharma-Bio Healthcare(KFPBH) Holding the 5th Technical-Business Partnership Meeting Holding the ISCT Asia 2023 Webinar (Korea)
• 2022 November Ministry of Health and Welfare(MoHW) approved the establishment of a non-profit corporation Renewed the MOU with FIRM in Japan Holding the 4th Technical-Business Partnership Meeting Holding the 3rd Advanced Regenerative Medicine Development Strategy Forum (KOREA LIFE SCIENCE WEEK 2022) Recruitment of companies participating in RM Pavilion October Participate in the TERMIS-AP 2022 Participate in the USP Cell&gene Therapy Roundtable Participate in the AusBiotech 2022 Discussion of Mutual Cooperation Plan September MOU with Student Career Development Division Incheon National University August Holding the 3rd Technical-Business Partnership Meeting Holding the CARM Open Innovation Investment Conference 2022 A meeting of the new chairman of the Health&Welfare Committee (The national assembly of the ROK) July Holding the 2nd CARM Open Innovation Day June Holding the 2nd Technical-Business Partnership Meeting Submission of opinion on Long Term Follow-up of Advanced Therapy Medicinal Product May MOU with Korea Investment Partners in Korea Holding the 1st CARM Open Innovation Day Participate in BIO KOREA 2022 Joint hosting of Regenerative Medicine Session Meeting with AusBiotech Discussion of Mutual Cooperation Plan Participate in The Australia NSW Clinical Trial·RM Showcase April Holding the 1st Technical-Business Partnership Meeting March MOU with BAYLI Partners in Korea MOU with BTCN in Korea January Inaugurated Dr. Kyung-Sun Kang, the founder of Kangstem Biotech as the third chairman of CARM MOU with GB Ventures and SJ Investment Partners in Korea
• 2021 November Holding the 2nd Advanced Regenerative Medicine Development Strategy Forum (KOREA LIFE SCIENCE WEEK 2021) October Participate in The 7th KoNECT International Conference (KIC) September Meeting with USP and KoreaBio Discussion of Cell&Gene Therapy Landscaping Project August MOU with RMAF (Regenerative Medicine Acceleration Foundation) in Korea MOU with KFRM (Korean Fund for Regenerative Medicine) in Korea June Recommending experts in the Bio-Health Regulation Roadmap Participate in BIO KOREA 2021 Joint hosting of Regenerative Medicine Session Holding the ISCT Asia 2021 Webinar (Korea)
• 2020 November Meeting with KoBIA (Korea Biomedicine Industry Association) Discussion of Mutual Cooperation Plan Holding the 1st Advanced Regenerative Medicine Development Strategy Forum (KOREA LIFE SCIENCE WEEK 2020) August-
  November Holding and participating in meetings to develop cell-based COVID 19 treatments (4 cases) July Participate in the 12st Thursday Dialogue hosted by the Prime Minister for the development of the biohealth industry Holding strategic seminars to establish the basic plan for advanced RM May Participate in BIO KOREA 2020 Joint hosting of Regenerative Medicine Session
• 2019 October Participate and presentation in AusBiotech 2019 Conference September Communicating with Ministry of Food and Drug Safety (MFDS) Discussion on the RM regulation and harmonization August Renewed the MOU with FIRM in Japan July Participate in APACRM (Asia Partnership Conference of Regenerative Medicine) meetings and Working Groups activites June Participate and presentation in Phacilitate Leaders Asia Conference May Operation of Korean booth in ISCT 2019 Annual Meeting April Joint hosting of BioKorea 2019 Regenerative Medicine Session Joint hosting of "Regenerative Medicine and Medical Innovation" Session in BioKorea 2019 Conference (CARM and KPBMA)
• 2018 November Signing of an MOU with ISCT of Canada Signing of an MOU with International Society for Cell & Gene Therapy (ISCT) May Inauguration of the second chairperson (Representative BG Rhee of SCM Lifescience) Change of name into "Council for Advanced Regenerative Medicine"
• 2017 June Signing of an MOU with ARM of the U.S. Signing of an MOU with Alliance for Regenerative Medicine (ARM),
  a cooperation network of regenerative medicine companies in the U.S., for the development of regenerative medicine industry both in Korea and the U.S. and the establishment of a network for mutual cooperation May Operation of Korean booth in ISCT 2017 Annual Meeting
• 2016 October Signing of an MOU with AusBiotech in Australia Signing of an MOU with AusBiotech, a Bio industry association in Australia, for the win-win growth of regenerative medicine industry both in Korea and Australia Signing of an MOU with FIRM in Japan Signing of an MOU with the Forum for Innovative Regenerative Medicine (FIRM), a cooperation network of regenerative medicine companies in Japan, for the development of regenerative medicine industry both in Korea and Japan and the establishment of a network for mutual cooperation May Inauguration of the first chairperson (Chairman Kwang Yul Cha of CHA Biotech) Launching of Consultative Group for Advanced Regenerative Medicine Starting ceremony held in Seoul Park Hyatt Hotel April Holding a meeting of the industry, academy, research institute and hospital presided by the Minister of Health and Welfare Discussing preparation of joint response strategies for the development of Korean industries and preoccupation of the Asian market in the future uniting around CARM
• 2015 December Holding advanced regenerative medicine business forum Discussing ways to promote win-win cooperation of advanced regenerative medicine companies in Korea July Forming the Preparatory Committee for the establishment of a cooperation network of regenerative medicine companies Holding 9 times of working session Holding a meeting of CEOs of regenerative medicine companies Discussing the necessity for the establishment of a network of regenerative medicine companies in Korea and reaching an agreement on the establishment of an industrial consultative group